Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (924) Arrow Down
Filter Results: (924) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,279)
    • People  (5)
    • News  (171)
    • Research  (924)
    • Events  (6)
    • Multimedia  (12)
  • Faculty Publications  (757)

Show Results For

  • All HBS Web  (1,279)
    • People  (5)
    • News  (171)
    • Research  (924)
    • Events  (6)
    • Multimedia  (12)
  • Faculty Publications  (757)
← Page 43 of 924 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • June 1999 (Revised June 2000)
  • Case

Eckerd Corporation

By: Michael E. Porter and John E. Kelleher
Describes the history and current situation in the retail pharmacy industry, including competition from new merchants and Internet drugstores. Eckerd, one of the top four drug chains, must decide how to position itself for the future. View Details
Keywords: Competition; Alignment; Supply and Industry; Pharmaceutical Industry; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Porter, Michael E., and John E. Kelleher. "Eckerd Corporation." Harvard Business School Case 799-141, June 1999. (Revised June 2000.)
  • 18 Aug 2017
  • Op-Ed

Op-Ed: Courageous Leader Triggers a Moral Revolt of CEOs Against Trump

actions was not without risk for the CEOs and their companies” While many CEOs prefer to stay under the radar and avoid public scrutiny, Ken Frazier led the way with his example. As the chair of PhRMA, the pharmaceutical manufacturers... View Details
Keywords: by Bill George
  • 20 May 2013
  • Op-Ed

Making America an Industrial Powerhouse Again

talent pool in the US biomedical field that is second to none. And the only way to get that talent is for companies-both domestic and foreign-to do their R&D here. That's why pharmaceutical and biotechnology companies from around the... View Details
Keywords: by Gary Pisano; Manufacturing
  • 07 Jun 2019
  • Book

Are You a Digital Manager?

might be working with peers in pharmaceuticals or defense to accelerate the development of virtual reality capabilities. In my work, I use the ethnographic methods of anthropology to study transformation as it takes place through shared... View Details
Keywords: by Martha Lagace
  • 28 Apr 2010
  • Research & Ideas

Earth Day Reflections

opportunity to engage in a virtual dialogue on these matters. Some major corporations are starting to take the lead in this effort, including United Technologies Corporation, Philips (the Dutch electronics and health care giant), the German chemical company BASF, and... View Details
Keywords: by Staff
  • 03 Mar 2009
  • First Look

First Look: March 3, 2009

pharmaceutical division and a diagnostic division. The company's antiviral drug Tamiflu dominates the market for prevention and treatment of seasonal influenza (flu). Tamiflu, however, could also play an important role in responding to... View Details
Keywords: Martha Lagace
  • 27 May 2009
  • First Look

First Look: May 27, 2009

Case 509-048 The case describes the effort of Merck, a global leader in pharmaceuticals, in making available its medicines to the poor. The challenge for the company (or for that matter, any pharmaceutical company) is how to integrate its... View Details
Keywords: Martha Lagace
  • 05 Mar 2001
  • What Do You Think?

Fine Coupling: Can Human Resource Management Learn from Supply Chain Management?

Productivity will improve as the alternation of job assignments eliminates the 'indispensable' worker." Connie Luthy says, "I have practiced 'Just-In-Time' hiring ... in the pharmaceutical industry.... I have advised my client... View Details
Keywords: by James Heskett
  • July 2005
  • Teaching Note

UCB: Managing Information for Globalization and Innovation (A)(TN)

By: F. Warren McFarlan
Teaching Note to (9-303-091). View Details
Keywords: Pharmaceutical Industry; Pharmaceutical Industry; Brussels
Citation
Purchase
Related
McFarlan, F. Warren. "UCB: Managing Information for Globalization and Innovation (A)(TN)." Harvard Business School Teaching Note 306-007, July 2005.
  • February 2003 (Revised August 2005)
  • Case

UCB (A): Managing Information for Globalization and Innovation

By: F. Warren McFarlan and Brian DeLacey
This case presents a complex total MIS strategy case for a $3 billion European pharmaceutical/chemicals company based in Brussels. It covers corporate strategy alignment of IT portfolio, IT operations issues, and global coordination of IT. View Details
Keywords: Information Technology; Operations; System; Corporate Strategy; Investment Portfolio; Globalization; Pharmaceutical Industry; Pharmaceutical Industry; Brussels
Citation
Educators
Purchase
Related
McFarlan, F. Warren, and Brian DeLacey. "UCB (A): Managing Information for Globalization and Innovation." Harvard Business School Case 303-091, February 2003. (Revised August 2005.)
  • 28 May 2014
  • Research & Ideas

Building Histories of Emerging Economies One Interview at a Time

business has a role to play in addressing it." For example, in one video clip, Yusuf Hamied, chairman of Mumbai-based pharmaceutical company Cipla, comments, "I'm a firm believer that if you're in the health care business like Cipla is,... View Details
Keywords: by Julia Hanna
  • 08 Aug 2011
  • Research & Ideas

The Death of the Global Manager

that are part of operating in today's world." Envisioning The Future Bartlett describes Transnational Management as being in a constant state of evolution. The most recently added chapter, "The Future of the Transnational," includes a case study on the... View Details
Keywords: by Julia Hanna
  • March 2017
  • Case

Cantel Medical

By: John R. Wells and Gabriel Ellsworth
Cantel Medical Corporation provided infection prevention and control products and services for patients, caregivers, and other healthcare providers. In 2016, Cantel generated sales of $665 million and net profits of $60 million, double the levels of five years earlier.... View Details
Keywords: Cantel; Charles Diker; Furniture Industry; Matrix Organization; Acquisition; Mergers and Acquisitions; Business Conglomerates; Business Units; Business Growth and Maturation; Business Organization; For-Profit Firms; Chemicals; Profit; Revenue; Geographic Scope; Multinational Firms and Management; Health; Health Care and Treatment; Business History; Business or Company Management; Goals and Objectives; Growth and Development Strategy; Organizational Structure; Problems and Challenges; Research and Development; Opportunities; Strategy; Adaptation; Business Strategy; Competitive Strategy; Corporate Strategy; Diversification; Expansion; Information Technology; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States; New Jersey
Citation
Educators
Purchase
Related
Wells, John R., and Gabriel Ellsworth. "Cantel Medical." Harvard Business School Case 717-482, March 2017.
  • 12 Jan 2016
  • First Look

January 12, 2016

November–December 2015 Operations Research Active Postmarketing Drug Surveillance for Multiple Adverse Events By: Goh, Joel, Margrét V. Bjarnadóttir, Mohsen Bayati, and Stefanos A. Zenios Abstract—Postmarketing drug surveillance is the process of monitoring the adverse... View Details
Keywords: Carmen Nobel
  • 07 Aug 2009
  • What Do You Think?

Why Can’t Americans Get Health Care Right?

above are numerous in a channel that includes, in your comments, food and tobacco producers of unhealthy products (Christy Hitchens, Tom Dolembo); lifestyle equipment and service providers; developers and manufacturers of high-cost View Details
Keywords: by Jim Heskett; Health
  • 04 Sep 2018
  • First Look

New Research and Ideas, September 4, 2018

It subsequently became much more arduous for pharmaceutical firms to bring new drugs to market. Some critics therefore argued that the new regulations were actually detrimental, as they prevented or delayed good drugs from coming to... View Details
Keywords: Dina Gerdeman
  • 24 Jan 2012
  • First Look

First Look: Jan. 24

This chapter proposes a new lens to understand corruption, using internal records collected from firms that pay bribes. We examine widespread corruption in three industries in an Asian developing country: procurement, pharmaceutical... View Details
Keywords: Sean Silverthorne
  • 19 Sep 2012
  • Research & Ideas

Funding Innovation: Is Your Firm Doing it Wrong?

the scale and resources of the corporate lab with some of the intensity and urgency associated with the venture capital model, you have something that can be very, very strong," Lerner says. The book describes how, in 2008, the View Details
Keywords: by Carmen Nobel
  • April 2022
  • Teaching Note

CVS Health: Prescription for Transformation

By: Rosabeth Moss Kanter and Catarina Martinez
In 2021, new CEO Karen Lynch (named the most powerful woman in business) considered the next transformation phase for CVS Health (a Fortune 5 corporate giant). The 2018 acquisition of Aetna insurance brought her to the company as part of its long evolution from a... View Details
Keywords: Health; COVID-19 Pandemic; Primary Care; Leadership; Change Management; Women Executives; Retail; Pharmacy; Pharmacy Benefit Manager; Clinical Trials; Vaccination; Acquisition; Innovation and Invention; Transformation; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States
Citation
Purchase
Related
Kanter, Rosabeth Moss, and Catarina Martinez. "CVS Health: Prescription for Transformation." Harvard Business School Teaching Note 322-122, April 2022.
  • May 2018
  • Case

The Multiple Myeloma Research Foundation's Answer Fund

By: Richard G. Hamermesh and Matthew G. Preble
Keywords: Data Analytics; Customer Focus and Relationships; Customer Relationship Management; Cost vs Benefits; Investment Return; Health Care and Treatment; Innovation Leadership; Intellectual Property; Knowledge Sharing; Knowledge Dissemination; Leadership; Leading Change; Resource Allocation; Goals and Objectives; Marketing Communications; Performance; Programs; Projects; Business and Community Relations; Business and Stakeholder Relations; Networks; Partners and Partnerships; Research and Development; Genetics; Behavior; Motivation and Incentives; Social and Collaborative Networks; Nonprofit Organizations; Strategy; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States
Citation
Educators
Related
Hamermesh, Richard G., and Matthew G. Preble. "The Multiple Myeloma Research Foundation's Answer Fund." Harvard Business School Case 818-045, May 2018.
  • ←
  • 43
  • 44
  • 45
  • 46
  • 47
  • →

Are you looking for?

→Search All HBS Web
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.